Ann: Official Supplier and Research Partner - ONE Championship, page-81

Yes MrBernanke, our newsflow is very juicy in the months to come.

We know the Perionditis trial has been registered, pending ethics approval and start.

I would like to bring to your attention the CannVaLate options vesting mechanism


We know that trial one is perionditis. From the way the expiry dates are laid out, it seems to me that Trials #2 and #3 will happen either consecutively or simultaneously. This could be due to the researchers at Swineburne University or cash reasons.

Trial #4 will clearly take a bit of time after trials 2 and 3 are registered.

So from what you have posted, and what was posted in the announcement RE Dr Sud's appointment about extensive discussions with sleep apnea centres, my bet is that Trials 2 and 3 will be the Dronabinol Trial for SLEEP APNEA and the use of CBD Oils for CONCUSSION.

Which would make the last trial the CBD Oils for Joint Dysfunction.

Either way we have a Jam PACKED lineup for the second half of 2019 and 2020. Good stuff!